Drug name - Eliquis
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6967208 | BRISTOL MYERS SQUIBB | Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
Nov, 2026
(4 years from now) | |
| CN101357914A | BRISTOL MYERS SQUIBB | Lactam-Containing Compounds And Derivatives Thereof As Factor Xa Inhibitors |
Apr, 2012
(10 years ago) | |
| CN1578660B | BRISTOL MYERS SQUIBB | Lactam Containing Compounds And Derivatives Thereof As Factor Xa Inhibitors |
Sep, 2022
(17 days ago) | |
| CN1578660A | BRISTOL MYERS SQUIBB | Lactam-Containing Compounds And Derivatives Thereof As Factor Xa Inhibitors |
Sep, 2022
(17 days ago) | |
| IN247381B | BRISTOL MYERS SQUIBB | A Novel Compound Of Formula (1) |
Sep, 2022
(17 days ago) | |
| IN200400590P1 | BRISTOL MYERS SQUIBB | A Novel Compound Of Formula (1) |
Sep, 2022
(17 days ago) | |
| EP2105436A1 | BRISTOL MYERS SQUIBB | Lactam-Containing Compounds And Derivatives Thereof As Factor Xa Inhibitors |
Sep, 2022
(17 days ago) | |
| EP2105436B1 | BRISTOL MYERS SQUIBB | Lactam-Containing Compounds And Derivatives Thereof As Factor Xa Inhibitors |
Sep, 2022
(17 days ago) | |
| EP1427415A1 | BRISTOL MYERS SQUIBB | Lactam-Containing Compounds And Derivatives Thereof As Factor Xa Inhibitors |
May, 2026
(3 years from now) | |
| EP1427415B1 | BRISTOL MYERS SQUIBB | Lactam-Containing Compounds And Derivatives Thereof As Factor Xa Inhibitors |
May, 2026
(3 years from now) | |
| EP1427415A4 | BRISTOL MYERS SQUIBB | Lactam-Containing Compounds And Derivatives Thereof As Factor Xa Inhibitors |
May, 2026
(3 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9326945 | BRISTOL MYERS SQUIBB | Apixaban formulations |
Feb, 2031
(8 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 2.5MG | TABLET;ORAL | Prescription |
| 5MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.